INTEC PHARMA LTD. Deferred Tax Assets, in Process Research and Development
INTEC PHARMA LTD. had Deferred Tax Assets, in Process Research and Development of $6.71 million as of 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2019-02-27
- 2018-12-31: Deferred Tax Assets, in Process Research and Development $6.71M.
- 2017-12-31: Deferred Tax Assets, in Process Research and Development $4.06M.
| Period end | Deferred Tax Assets, in Process Research and Development |
|---|---|
| 2018-12-31 | $6.71M 10-K · filed 2019-02-27 |
| 2017-12-31 | $4.06M 10-K · filed 2019-02-27 |